SYS-CON MEDIA Authors: Bob Gourley, Lori MacVittie, RealWire News Distribution, Cynthia Dunlop, Mark O'Neill

News Feed Item

BioMed Realty Trust Announces Tax Treatment Of 2013 Distributions

SAN DIEGO, Jan. 17, 2014 /PRNewswire/ -- BioMed Realty Trust, Inc. (NYSE: BMR) today announced the tax treatment of its 2013 distributions as follows:

Security Description: Common Stock
CUSIP: 09063H107
Ticker Symbol: BMR


Record Date

Payable Date

Total Distribution

Per Share

Allocable to 2013

Taxable Ordinary Dividend

 

Return of Capital

Long-Term Capital Gain

Unrecaptured Section 1250 Gain

12/31/2012

1/15/2013

$0.235000

$0.235000

$0.235000

$0.000000

$0.000000

$0.000000

3/28/2013

4/15/2013

$0.235000

$0.235000

$0.235000

$0.000000

$0.000000

$0.000000

6/28/2013

7/15/2013

$0.235000

$0.235000

$0.235000

$0.000000

$0.000000

$0.000000

9/30/2013

10/15/2013

$0.235000

$0.235000

$0.235000

$0.000000

$0.000000

$0.000000

Totals

$0.940000

$0.940000

$0.940000

$0.000000

$0.000000

$0.000000

 

Security Description: 7.375% Series A Cumulative Redeemable Preferred Stock
CUSIP: 09063H206
Ticker Symbol: BMR PR A


Record Date

Payable Date

Total Distribution

Per Share

Allocable to 2013

Taxable Ordinary Dividend

 

Return of Capital

Long-Term Capital Gain

Unrecaptured Section 1250 Gain

12/31/2012

1/15/2013

$0.460940

$0.460940

$0.460940

$0.000000

$0.000000

$0.000000

3/15/2013

3/15/2013(1)

$0.302170

$0.302170

$0.302170

$0.000000

$0.000000

$0.000000

Totals

$0.763110

$0.763110

$0.763110

$0.000000

$0.000000

$0.000000

(1) Redeemed on March 15, 2013.

The distributions payable on January 15, 2014 to shareholders of record on December 31, 2013, as previously declared on December 12, 2013, are considered 2014 distributions for federal income tax purposes.

The company did not incur any foreign taxes during 2013.  Stockholders are encouraged to consult with their personal tax advisors as to their specific tax treatment of BioMed Realty Trust distributions.

About BioMed Realty Trust

BioMed Realty, with its trusted expertise and valuable relationships, delivers optimal real estate solutions for biotechnology and pharmaceutical companies, scientific research institutions, government agencies and other entities involved in the life science industry. BioMed Realty owns or has interests in properties comprising approximately 16.3 million rentable square feet.  Additional information is available at www.biomedrealty.com.

 

 

SOURCE BioMed Realty Trust, Inc.

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.